In This Article:
-
Ferrari, following the accelerated bookbuild offering announced by Exor on February 26, 2025, intends to repurchase up to 10% of Exor’s total offering up to a maximum of Euro 300 million
-
This share repurchase is to be considered as a part of Ferrari’s multi-year Euro 2.0 billion share buyback program as announced during our 2022 CMD. It will constitute the seventh tranche and it will be financed by Ferrari’s cash on hand
-
On February 20, 2025, Ferrari completed the sixth tranche announced on December 5, 2024
Maranello (Italy), February 26, 2025 – Ferrari N.V. (NYSE/EXM: RACE) (“Ferrari” or the “Company”) announces that, following the accelerated bookbuild offering (“ABO”) of Ferrari shares made today by Exor N.V. (“Exor”), it intends to participate in the offering by repurchasing up to 10% of Exor’s total offering for up to a maximum of Euro 300 million. The transaction will be executed by participating in the ABO announced by Exor at the same price per share determined in the offering.
This transaction represents the seventh tranche of the multi-year share buyback program of approximately Euro 2.0 billion announced during our 2022 Capital Markets Day (the “Program”) and it falls within the limitations of the share buyback mandate approved at the April 17, 2024 Annual General Meeting of Shareholders, duly communicated to the market, which authorized the purchase of up to 10% of the Company’s common shares during the eighteen-month period following such Shareholders’ Meeting.
Details of the repurchase transactions carried out under the seventh tranche will be disclosed to the market as required by applicable regulation.
The repurchase will be financed by Ferrari’s cash on hand and it will not affect Ferrari’s ability to execute its strategic plan and its financing capabilities.
In addition, Ferrari informs that the Company has purchased, under the Euro 150 million sixth tranche of the Program announced on December 5, 2024 (the “Sixth Tranche”), the following common shares - reported in aggregate form, on a daily basis – on the Euronext Milan (EXM and on the New York Stock Exchange (NYSE):
| EXM | NYSE | Total | |||||||
Trading | Number of common shares purchased | Average price per share | Consideration excluding fees | Number of common shares purchased | Average price per share | Consideration excluding fees | Consideration excluding fees | Number of common shares purchased | Average price per share | Consideration excluding fees |
|
|
|
|
|
|
|
| |||
17/02/2025 | 1,946 | 486.3676 | 946,471.40 | - | - | - | - | 1,946 | 486.3676 | 946,471.40 |
18/02/2025 | 15,576 | 487.9137 | 7,599,743.50 | 6,954 | 503.1803 | 3,499,115.81 | 3,349,397.73 | 22,530 | 485.9805 | 10,949,141.23 |
19/02/2025 | 9,185 | 482.5296 | 4,432,034.60 | 8,898 | 500.9449 | 4,457,407.72 | 4,272,002.80 | 18,083 | 481.3381 | 8,704,037.40 |
20/02/2025 | 9,181 | 481.0669 | 4,416,675.40 | - | - | - | - | 9,181 | 481.0669 | 4,416,675.40 |
| 35,888 | 484.7003 | 17,394,924.90 | 15,852 | 501.9255 | 7,956,523.53 | 7,621,400.53 | 51,740 | 483.5007 | 25,016,325.43 |
Total | ||||||||||
|
(*) translated at the European Central Bank EUR/USD exchange reference rate as of the date of each purchase